Blog Posts

Blog Posts

Conclusive Engineering’s KSTR-SAMA5D27: Ultra-Compact, Low-Power SBC using Microchip SAMA5D27 SiP – CNX Software

KSTR-SAMA5D27 SBC

Conclusive Engineering KSTR-SAMA5D27  is an ultra-compact (70x50mm) single board computer (SBC) powered by a Microchip SAMA5D27 Arm Cortex-A5 processor microprocessor clocked at 500 MHz paired with 256MB LPDDR2 (system-in-package). The board also features a microSD card slot and EEPROM for storage/configuration, Fast Ethernet, WiFi 4, and Bluetooth 4.1 connectivity, a USB-C port, two GPIO headers, and supports USB and battery power. It’s designed for IoT devices, smart systems, and edge computing applications. Conclusive Engineering KSTR-SAMA5D27 specifications: SiP –  Microchip SAMA5D27 CPU – Arm Cortex-A5 microprocessor @ 500 MHz System Memory – 256 MB LPDDR2 Storage MicroSD card slot 4KB EEPROM Networking 10/100Mbps Ethernet RJ45 jack 2.4 GHz WLAN IEEE 802.11 b/g/n and Bluetooth 4.1 USB 1x USB 2.0 OTG Type-C connector 1x USB 2.0 Host on expansion header Expansion 34-pin and 30-pin connectors 2x Flexcom (configurable: I2C, SPI, UART) I2C 6-channel ADC with Vref 10-bit ISC (Image Sensor Controller), 10-bit […]

The post Conclusive Engineering KSTR-SAMA5D27 is an ultra-compact, low-power SBC based on Microchip SAMA5D27 SiP appeared first on CNX Software – Embedded Systems News.

By
Conclusive Engineering's KSTR-SAMA5D27: Ultra-Compact, Low-Power SBC using Microchip SAMA5D27 SiP - CNX Software
Uncategorized

Netgear Obtains FCC Exemption from Router Prohibition

Federal Communications Commission (FCC) prohibited routers manufactured in other nations due to claims that they “represent an unacceptable threat to the national security of the United States.” We may have jumped the gun, as the FCC is not entirely banning them, particularly if they are crucial for military functions.

Recently, the FCC released an updated public announcement concerning the foreign-made router prohibition. The notice indicates that Netgear (an American-based company that produces its products in locations such as Vietnam and Thailand) has received a “Conditional Approval” to keep selling in the United States. While the notice does not specify the exact rationale, it mentions that Conditional Approval may be granted to any firm that requests it as long as it manufactures uncrewed aircraft systems (UAS) and UAS “critical components.” Naturally, the company must also demonstrate that its routers do not pose substantial threats to national security. We can reasonably deduce that Netgear accomplished this not only due to a convincing argument but also because its routers are integral to UAS functionality.

Given that Netgear may have attained this advantage partly because its routers facilitate UAV control, one might speculate that a stipulation of the Conditional Approval is that Netgear is limited to selling routers exclusively to U.S. government agencies. However, this is not accurate. As per the public notice, Netgear is also permitted to market consumer-level mesh, mobile, and standalone routers in the Orbi and Nighthawk series (which are among the best budget routers available on Amazon), along with cable gateways and modems.

Netgear isn’t the sole exception

When the FCC endeavored to limit foreign-made routers, the organization assessed devices to determine whether they posed undue risks to the U.S. government and if they constituted “UAS critical components.” Netgear routers were not the initial devices to receive a pass, and they may not be the final ones.

As of this moment, Adtran Inc’s Service Delivery Gateway routers

By
Netgear Obtains FCC Exemption from Router Prohibition
Uncategorized

Apple Wins in Masimo Controversy as ITC Wraps Up Investigation into Apple Watch Import Ban

Apple has recently secured a major win in its protracted legal battle with Masimo, a company specializing in health technology, over patents related to the blood oxygen monitoring feature of the Apple Watch. This article outlines the circumstances surrounding the dispute.

### Background of the Dispute

The clash between Apple and Masimo has persisted for several years, focusing on the blood oxygen sensor technology embedded in the Apple Watch. Following a series of legal rulings and appeals, Apple was forced to disable this feature on Apple Watches marketed in the United States to circumvent a ban. In response, Apple engineered a revamped version of the feature that transferred most processing to the iPhone, using data gathered from the Apple Watch.

The International Trade Commission (ITC) concluded that this redesign permitted Apple to recommence sales of the Apple Watch models featuring blood oxygen monitoring in the U.S., determining that it did not infringe Masimo’s patents. Nevertheless, Masimo disputed this finding, claiming that Apple’s redesign still contravened the existing exclusion order and contested U.S. Customs and Border Protection’s endorsement of the updated watches.

### Recent Developments

Two significant decisions emerged from this protracted legal confrontation:

1. An ITC Administrative Law Judge, Monica Bhattacharyya, ruled that Apple’s revamped blood oxygen feature does not violate Masimo’s patents.
2. The Federal Circuit upheld the ITC’s initial exclusion order, affirming that the original version of the blood oxygen feature remains prohibited in the United States.

The concluding step in this process was for the entire ITC Commission to decide whether to review the Administrative Law Judge’s no-infringement ruling.

### ITC’s Decision

On March 30, 2026, the ITC opted not to revisit the prior ruling, effectively concluding the case and dismissing Masimo’s plea to reinstate the Apple Watch import ban. The ruling validated that the redesigned products do not infringe the asserted patents, enabling Apple to persist in providing the blood oxygen feature to its consumers.

In a statement, Apple expressed appreciation for the ITC’s ruling, underscoring its dedication to safeguarding its innovations. The company highlighted its commitment to delivering premium products and services, including health features such as the ECG app and notifications for hypertension and irregular rhythms.

### Conclusion

While Apple revels in this legal triumph, Masimo still retains the ability to appeal the decision. This case illustrates the intricacies of patent legislation in the technology sector and the ongoing rivalry between companies in the health technology domain. As Apple progresses in innovating and broadening its health-related features, the ramifications of this legal dispute will have enduring impacts for both corporations and their clientele.

By
Apple Wins in Masimo Controversy as ITC Wraps Up Investigation into Apple Watch Import Ban
Uncategorized